April 12, 2022 – The Minneapolis Heart Institute Foundation (MHIF) has announced the first presentation and simultaneous ...
April 12, 2022 – iRhythm Technologies, Inc., a leading digital healthcare solutions company focused on the advancement ...
April 12, 2022 — The American College of Cardiology has issued an expert consensus decision pathway for the evaluation ...
April 8, 2022 – Physicians prescribed significantly more guideline-directed medications for heart failure if they ...
April 8, 2022 – Patients taking renin-angiotensin-aldosterone system inhibitor (RAASi) medications for heart failure had ...
April 8, 2022 – Patients who received a transcatheter supra-annular self-expanding heart valve had significantly less ...
April 7, 2022 – Among patients undergoing non-cardiac surgery who were also on blood pressure medications, a ...
April 7, 2022 – Patients with tricuspid regurgitation, a common and debilitating form of valvular heart disease, who ...
April 7, 2022 – Patients treated with the blood thinner edoxaban for six months after a heart valve replacement ...
April 7, 2022 – The American College of Cardiology’s Global Heart Attack Treatment Initiative (GHATI) reports continuing ...
April 7, 2022 – While there are effective therapies to reduce the risk of heart disease by lowering low-density ...
April 6, 2022 – Final results from the BIO|GUARD-MI study show a 31 percent reduction of MACE in a sub-group analysis of ...
April 6, 2022 – Deaths among hospitalized patients who had both COVID-19 and the most severe type of heart attack were ...
April 6, 2022 – Donisi Health, a MedTech company working to disrupt the readmission cycle of congestive heart failure ...
April 4, 2022 – The American College of Cardiology's Evolving Practice of Cardiovascular Precision Medicine course on ...